HEICO’s VPT, Inc. and 3D Plus Subsidiaries Supply

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
HEICO’s VPT, Inc. and 3D Plus Subsidiaries Supply Mission-Critical Components on NASA’s OSIRIS-REx

BLACKSBURG, Va., BUC, France and MIAMI, Sept. 09, 2016 (GLOBE NEWSWIRE) -- HEICO Corporation (NYSE:HEI.A) (NYSE: HEI ) today reported that its VPT, Inc. and 3D Plus subsidiaries supplied mission-critical components for NASA’s OSIRIS-REx program, which launched from Cape Canaveral, FL last night.

The Origins, Spectral Interpretation, Resource Identification, Security-Regolith Explorer (OSIRIS-REx) spacecraft is designed to rendezvous with, study, and return a sample of the asteroid Bennu to Earth.  It will be the first US mission to carry samples from an asteroid back to Earth and the largest sample returned from space since the Apollo era.

VPT, Inc. supplied parts onboard the Atlas V launch vehicle and DC-to-DC power converters on the laser altimeter on the spacecraft.  3D Plus supplied Space Memory Modules on the spacecraft, which will rendezvous with the asteroid.

Blacksburg, Virginia-based VPT, Inc. and Buc, France-based 3D Plus have, between them, supplied critical components on numerous NASA missions, including the Juno, New Horizons, Dawn and Curiosity spacecraft.

NASA's Goddard Space Flight Center provides overall mission management, systems engineering and the safety and mission assurance for OSIRIS-REx.  The University of Arizona leads the science team and observation planning and processing.  Lockheed Martin Space Systems in Denver built the spacecraft.  OSIRIS-REx is the third mission in NASA’s New Frontiers Program.  NASA’s Marshall Space Flight Center in Huntsville, Alabama, manages the agency’s New Frontiers Program for its Science Mission Directorate in Washington.  Launch and countdown management is the responsibility of NASA’s Kennedy Space Center in Florida.

Laurans A. Mendelson, HEICO’s Chairman and Chief Executive Officer, and Victor H. Mendelson, HEICO’s Co-President, jointly stated, “HEICO congratulates the entire NASA team on yet another spectacular launch.  We also congratulate the entire VPT and 3D Plus teams on their roles in the mission.  We’re proud to be affiliated with such a remarkable group of people.”

HEICO Corporation is engaged primarily in the design, production, servicing and distribution of products and services to certain niche segments of the aviation, defense, space, medical, telecommunications and electronics industries through its Hollywood, Florida-based Flight Support Group and its Miami, Florida-based Electronic Technologies Group.  HEICO's customers include a majority of the world's airlines and overhaul shops, as well as numerous defense and space contractors and military agencies worldwide, in addition to medical, telecommunications and electronics equipment manufacturers.  For more information about HEICO, please visit our website at http://www.heico.com .

The Company has two classes of common stock traded on the NYSE.  Both classes, the Class A Common Stock (HEI.A) and the Common Stock (HEI), are virtually identical in all economic respects.  The only difference between the share classes is the voting rights.  The Class A Common Stock (HEI.A) has 1/10 vote per share and the Common Stock (HEI) has one vote per share.  The stock symbols for HEICO's two classes of common stock on most web sites are HEI.A and HEI.  However, some web sites change HEICO's Class A Common Stock symbol (HEI.A) to HEI/A or HEIa.

Victor H. Mendelson (305) 374-1745 ext. 7590

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles